{
 "name": "達亞",
 "slug": "tw-6762",
 "aliases": [
  "達亞國際股份有限公司",
  "Delta Asia",
  "6762"
 ],
 "ticker": "6762",
 "industry": "生技醫療業",
 "website": "https://www.deltaasia.com.tw/",
 "summary": "達亞（6762）是上櫃的生技醫療類股公司，2004 年成立，2020 年上櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "達亞國際股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "英文簡稱",
   "value": "Delta Asia",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心上櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "上櫃日期",
   "value": "2020-12-18",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "成立日期",
   "value": "2004-11-16",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "董事長",
   "value": "許雅雯",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "總經理",
   "value": "許雅雯",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "實收資本額",
   "value": 369302880,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "資誠聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "公司網址",
   "value": "https://www.deltaasia.com.tw/",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "月營收（2026-09）",
   "value": 68331,
   "unit": "新台幣千元",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔二手來源不在白名單；回查官方115年09月營收申報，claim/value/unit/as_of與原值一致並保留。出表日期1151017；僅更正source及補note。"
  },
  {
   "claim": "月營收年增率（2026-09）",
   "value": 26.5,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔二手來源不在白名單；回查官方115年09月營收申報，claim/value/unit/as_of與原值一致並保留。出表日期1151017；僅更正source及補note。"
  },
  {
   "claim": "累計營收年增率（2026 年 1 月至 09 月）",
   "value": 7.33,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔二手來源不在白名單；回查官方115年09月營收申報，claim/value/unit/as_of與原值一致並保留。出表日期1151017；僅更正source及補note。"
  },
  {
   "claim": "主要產品：胰島素注射器材",
   "value": "已完成相關生產製程認證；列2026年量產重點",
   "unit": "",
   "as_of": "2026-03-20",
   "source": "https://www.deltaasia.com.tw/proimage/images/1777367350.pdf",
   "note": "2025年度年報（封面2026-03-20刊印）；達亞供應客戶醫材零組件及組裝服務，產品最終許可不等於達亞自有藥證。"
  },
  {
   "claim": "主要產品：心血管微創手術器材",
   "value": "心臟瓣膜修復傳輸器材、心導管術後止血器材及腹主動脈覆膜支架系統植入手術器材",
   "unit": "",
   "as_of": "2026-03-20",
   "source": "https://www.deltaasia.com.tw/proimage/images/1777367350.pdf",
   "note": "2025年度年報（封面2026-03-20刊印）；達亞供應客戶醫材零組件及組裝服務，產品最終許可不等於達亞自有藥證。"
  },
  {
   "claim": "主要產品：腎臟微創手術及透析器材",
   "value": "腎結石移除微創手術器材、居家血液透析設備器材",
   "unit": "",
   "as_of": "2026-03-20",
   "source": "https://www.deltaasia.com.tw/proimage/images/1777367350.pdf",
   "note": "2025年度年報（封面2026-03-20刊印）；達亞供應客戶醫材零組件及組裝服務，產品最終許可不等於達亞自有藥證。"
  },
  {
   "claim": "催化劑：胰島素注射器材",
   "value": "進入大量生產階段｜2026（公司預估）｜已公告",
   "unit": "",
   "as_of": "2026-03-20",
   "source": "https://www.deltaasia.com.tw/proimage/images/1777367350.pdf",
   "note": "未查得後續完成確認；保留年度預估，不推算季度或確切日。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-6762.json",
 "generated_at": "2026-10-23T01:06:05.573Z"
}